Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins.
Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins.
复制标题
DOI:
10.1016/j.vaccine.2017.02.064
复制
发表时间:
2017-04-25
期刊:
影响因子:
5.5
通讯作者:
Boyaka PN
中科院分区:
文献类型:
--
作者:
Martin TL;Jee J;Kim E;Steiner HE;Cormet-Boyaka E;Boyaka PN
Anthrax is caused by Bacillus anthracis, a zoonotic bacterial pathogen affecting humans and livestock worldwide. The current human anthrax vaccine, anthrax vaccine adsorbed (AVA), is an injected vaccine with a cumbersome administration schedule and fails to promote mucosal immunity. Bacterial enterotoxins, which stimulate production of the cyclic nucleotide cAMP are effective experimental mucosal vaccine adjuvants, but their inherent toxicity has precluded their use in humans. We investigated whether cyclic dinucleotides that target Stimulator of Interferon Gamma Genes (STING) in mammalian cells could represent an alternative to bacterial enterotoxins as adjuvant for sublingual immunization and promotion of mucosal immunity and secretory IgA responses in addition to systemic immunity. We found that sublingual immunization of mice with Bacillus anthracis protective antigen (PA) and the STING ligand 3′3′-cGAMP promotes PA-specific serum IgG Ab responses of the same magnitude as those induced after immunization with PA and the experimental adjuvants cholera toxin (CT). Interestingly, this STING ligand also promoted serum anti-PA IgA and IgA-producing cells in the bone marrow. Furthermore, the saliva of mice immunized with the STING ligand exhibited similar levels of PA-specific IgA Abs as groups immunized with CT as adjuvant. The adjuvant activity of 3′3′-cGAMP was associated with mixed Th1, Th2, and Th17 responses. This STING ligand also induced rapid IFN-β and IL-10 responses in sublingual tissues and cervical lymph nodes, and TGF-β responses in the cervical lymph nodes, which could contribute to promoting IgA responses after sublingual immunization.
登录
查看更多内容
影响因子:
5.4
作者:
Bhat N;Fitzgerald KA
通讯作者:
Fitzgerald KA
DOI:
10.1126/science.1244040
发表时间:
2013-09-20
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Li XD;Wu J;Gao D;Wang H;Sun L;Chen ZJ
通讯作者:
Chen ZJ
DOI:
10.4049/jimmunol.0803740
发表时间:
2009-12-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Cuburu N;Kweon MN;Hervouet C;Cha HR;Pang YY;Holmgren J;Stadler K;Schiller JT;Anjuère F;Czerkinsky C
通讯作者:
Czerkinsky C
DOI:
10.3390/v3060906
发表时间:
2011-06
期刊:
Viruses
影响因子:
--
作者:
Ireton RC;Gale M Jr
通讯作者:
Gale M Jr
影响因子:
17.1
作者:
Fu J;Kanne DB;Leong M;Glickman LH;McWhirter SM;Lemmens E;Mechette K;Leong JJ;Lauer P;Liu W;Sivick KE;Zeng Q;Soares KC;Zheng L;Portnoy DA;Woodward JJ;Pardoll DM;Dubensky TW Jr;Kim Y
通讯作者:
Kim Y